As of February 10, 2023, the average one-year price target for Vivos Therapeutics is $2.30. The forecasts range from a low of $2.02 to a high of $2.62. The average price target represents an increase ...
Vivo, the Chinese smartphone manufacturer, has officially released its self-developed operating system called BlueOS. The company announced the new OS at its 2023 Vivo Developer Conference. Vivo says ...
HIGHLANDS RANCH, Colo., Oct. 13, 2021 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (the “Company” or “Vivos”) (NASDAQ: VVOS), a medical technology company focused on developing and commercializing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results